Order byBest matchMost fresh

Johnson & Johnson slips

Digest more
Top News
Overview
Next steps
The Boston Globe |
Johnson & Johnson has long denied those claims, but has in recent years stopped selling talc-based baby powder worldwide.
Business Insider |
American pharmaceutical giant Johnson & Johnson (JNJ) has once again faced rejection on its $10 billion plan to settle thousands of lawsuits alleging its baby powder and other talc products cause ovar...
Seattle Times |
J&J said in a statement that it will not pursue an appeal, and instead will return to the civil law system “to litigate and defeat these meritless talc claims.”

Read more on News Digest

Johnson & Johnson loses in court again in bid to settle talc cases
A federal bankruptcy judge in Houston on Monday rejected Johnson & Johnson’s request to approve a $9 billion settlement with tens of thousands of people who are suing the company over claims that its talcum powder products caused cancer.
US judge rejects J&J's $10 bln bid to settle talc cancer claims
A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company's bankruptcy strategy has failed in court.
Morning Movers: Johnson & Johnson slips after rejection of Talc case settlement
Stock index futures are experiencing early declines amid investor apprehension surrounding President Donald Trump’s impending “Liberation Day”
J&J’s (JNJ) Bankruptcy Plan to Settle Talc Cancer Claims Faces Rejection
American pharmaceutical giant Johnson & Johnson (JNJ) has once again faced rejection on its $10 billion plan to settle thousands of
Johnson & Johnson Loses in Court Again in Bid to Settle Talc Cases
A judge dismissed an attempt to use a bankruptcy court to resolve tens of thousands of claims that the company’s talcum power products caused cancer.
Johnson & Johnson completes Intra-Cellular Therapies acquisition, sees dilution
Johnson & Johnson announced it has completed its acquisition of Intra-Cellular Therapies. Intra-Cellular Therapies is now part of Johnson
Bankruptcy judge denies J&J settlement plan related to baby powder containing talc
A U.S. bankruptcy court judge has denied Johnson & Johnson’s settlement plan related to baby powder containing talc, providing another setback in the company’s efforts to resolve the matter.
Johnson & Johnson talc litigation ‘hit another snag,’ says Citi
Citi says Johnson & Johnson’s talc litigation “hit another snag,” with the judge in the bankruptcy case denying management’s proposed
US judge rejects J&J's $10 billion baby powder settlement
A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company's bankruptcy strategy has failed in court.
Johnson & Johnson plans $55 billion in US investments over the next four years
Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four new manufacturing plants
GlobeSt9d
Johnson & Johnson Commits $55B to U.S. Healthcare Expansion
According to an announcement by the pharmaceutical company, Johnson & Johnson (JNJ) will invest over $55 billion in various healthcare sectors in the U.S. during the next four years, including a major North Carolina facility. That would mark an increase of 25 percent compared with the previous four years.
Marketplace17h
Johnson & Johnson tried 3 times to resolve talc suits in bankruptcy court. It didn’t work.
A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby powder caused cancer.
Feedback